Marc Bardou
Inserm · 315 works · 11,681 citations · h-index 45
Top works
- International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
- Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
- Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- Management of Acute Bleeding from a Peptic Ulcer
- Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group
- Magnetic Resonance Cholangiopancreatography
- Obesity and colorectal cancer
- Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses
- Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleeding
- Proton Pump Inhibitors vs. Histamine 2 Receptor Antagonists for Stress-Related Mucosal Bleeding Prophylaxis in Critically Ill Patients: A Meta-Analysis
- Methodology for Randomized Trials of Patients With Nonvariceal Upper Gastrointestinal Bleeding: Recommendations From an International Consensus Conference
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
- Prokinetics in acute upper GI bleeding: a meta-analysis
- Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
- Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)
- High‐dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost‐effectiveness analysis
- Effect of statin therapy on colorectal cancer
- Stress-related mucosal disease in the critically ill patient
- The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence